Claudin-6

Claudin-6 Overview

English NameClaudin 6Approved Drugs0
Drugs in Clinical Trials13Target SynonymUNQ757/PRO1488,Claudin-6,CLDN6,Claudin 6,Skullin
Highest Development StagePhase 2 Clinical
English NameClaudin 6
Target SynonymUNQ757/PRO1488,Claudin-6,CLDN6,Claudin 6,Skullin
Approved Drugs0
Drugs in Clinical Trials13
Highest Development StagePhase 2 Clinical

Claudin-6 Background

Tight junctions represent one mode of cell-to-cell adhesion in epithelial or endothelial cell sheets, forming continuous seals around cells and serving as a physical barrier to prevent solutes and water from passing freely through the paracellular space. These junctions are comprised of sets of continuous networking strands in the outwardly facing cytoplasmic leaflet, with complementary grooves in the inwardly facing extracytoplasmic leaflet. Claudin-6, also knows as CLDN6, is a multipass transmembrane protein in the Claudin family. Claudin-6 is expressed by epithelial cells where it participates in tissue development and the maintenance of tight junction integrity. And it is one of the entry cofactors for hepatitis C virus. The methylation of CLDN6 may be involved in esophageal tumorigenesis. The gene of CLDN6 is adjacent to another family member CLDN9 on chromosome 16.

Claudin-6 Synonyms

Claudin-6,CLDN6

Antibody Project Trading Platform

Project NameProject StageMolecule TypeMolecule SourceDisease AreaIndication
CLDN6 mAb - 01PCCMonoclonalHumanized MouseSolid TumorOvarian cancer,Lung adenocarcinoma

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
QLS-5132QLS5132; QLS-5132Phase 2 ClinicalQilu Pharmaceutical Co LtdCarcinoma, Non-Small-Cell Lung; Endometrial Neoplasms; Ovarian Neoplasms; Solid tumours; Stomach Neoplasms
Details
TORL-1-23TORL-1-23Phase 2 ClinicalTorl Biotherapeutics LLCCarcinoma, Non-Small-Cell Lung; Carcinoma, Ovarian Epithelial; Endometrial Neoplasms; Fallopian Tube Diseases; Fallopian Tube Neoplasms; Ovarian Neoplasms; Peritoneal Diseases; Peritoneal Neoplasms; Solid tumours
Details
PLB-002PLB-002; PLB002Phase 1 ClinicalPrimeLink BioTherapeuticsEndometrial Neoplasms; Ovarian Neoplasms; Solid tumours; Testicular Neoplasms
Details
BGB-B455BGB-B455Phase 1 ClinicalBeOne Medicines LtdSolid tumours
Details
AT03-65AT-03-65; AT03-65Phase 1 ClinicalAxcynsis Therapeutics Pte LtdSolid tumours
Details
ARC-101ARC101; ARC-101Phase 1 ClinicalThird Arc Bio IncEndometrial Neoplasms; Lung Neoplasms; Ovarian Neoplasms; Solid tumours
Details
CTIM-76CTIM-76Phase 1 ClinicalIntegral Molecular IncEndometrial Neoplasms; Neoplasms; Ovarian Neoplasms; Solid tumours; Testicular Neoplasms
Details
NBL-028NBL028; NBL-028Phase 1 ClinicalNovarock Biotherapeutics Ltd, Shanghai Xinshi Biological Medicine Co LtdCarcinoma, Non-Small-Cell Lung; Endometrial Neoplasms; Neoplasms; Ovarian Neoplasms; Solid tumours; Stomach Neoplasms; Testicular Neoplasms
Details
XmAb-541XmAb541; XmAb-541Phase 1 ClinicalXencor IncEndometrial Neoplasms; Germinoma; Neoplasms, Germ Cell and Embryonal; Ovarian germ cell tumor; Ovarian Neoplasms
Details
SAIL-66SAIL66; SAIL-66Phase 1 ClinicalChugai Pharmaceutical Co LtdSolid tumours
Details
CLDN6-CAR-NK Cell TherapyPhase 1 ClinicalSecond Affiliated Hospital Of Guangzhou Medical UniversityEndometrial Neoplasms; Ovarian Neoplasms
Details
TJ-C64BTJ-C64BPhase 1 ClinicalI-Mab Biopharma Co LtdOvarian Neoplasms; Stomach Neoplasms
Details
CLDN6 CAR-T cell therapy (BioNTech)BNT-211Phase 1 ClinicalBiontech SeGerminoma; Neoplasms, Gonadal Tissue; Solid tumours; Testicular Neoplasms
Details
  • Overview
  • Product List
  • Clinical Drug Information
Contact Us

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호